Reviewing SBC Medical Group (NASDAQ:SBC) & Solventum (NYSE:SOLV)

SBC Medical Group (NASDAQ:SBC) and Solventum (NYSE:SOLV) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, risk, earnings, dividends, analyst recommendations, institutional ownership and valuation.

Profitability

This table compares SBC Medical Group and Solventum’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
SBC Medical Group	29.37%	20.76%	15.67%
Solventum	18.69%	25.26%	7.40%

Valuation & Earnings

This table compares SBC Medical Group and Solventum”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SBC Medical Group	$173.61 million	2.20	$50.99 million	$0.49	7.59
Solventum	$8.33 billion	1.46	$1.56 billion	$8.87	7.90

Solventum has higher revenue and earnings than SBC Medical Group. SBC Medical Group is trading at a lower price-to-earnings ratio than Solventum, indicating that it is currently the more affordable of the two stocks.

Volatility and Risk

SBC Medical Group has a beta of 0.99, suggesting that its stock price is 1% less volatile than the S&P 500. Comparatively, Solventum has a beta of 0.71, suggesting that its stock price is 29% less volatile than the S&P 500.

Institutional & Insider Ownership

60.8% of SBC Medical Group shares are held by institutional investors. 89.5% of SBC Medical Group shares are held by company insiders. Comparatively, 0.2% of Solventum shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Analyst Ratings

This is a breakdown of recent ratings and target prices for SBC Medical Group and Solventum, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SBC Medical Group	1	0	2	0	2.33
Solventum	1	5	7	0	2.46

SBC Medical Group presently has a consensus price target of $8.50, suggesting a potential upside of 128.49%. Solventum has a consensus price target of $90.09, suggesting a potential upside of 28.59%. Given SBC Medical Group’s higher possible upside, research analysts plainly believe SBC Medical Group is more favorable than Solventum.

About SBC Medical Group

SBC Medical Group Holdings Incorporated, through its subsidiaries, provides services to support the operation of clinics which deliver specialized medical services in the areas of cosmetic medicine, esthetic dentistry and Androgenetic Alopecia or AGA, primarily in Japan and centered on the SBC Shonan Beauty Clinic Brand. SBC Medical Group Holdings Incorporated, formerly known as Pono Capital Two Inc., is based in TOKYO.

About Solventum

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes. The Dental Solutions segment provides a comprehensive suite of dental and orthodontic products including brackets, aligners, restorative cements, and bonding agents. The Health Information Systems provides software solutions including computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech, recognition, and data visualization platforms. The Purification and Filtration segment provides purification and filtration technologies including filters, purifiers, cartridges, and membranes. The company was incorporated in 2023 and is based in Saint Paul, Minnesota.